AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression

被引:9
|
作者
Ma, Peng [1 ]
Hao, Ying [1 ]
Wang, Wei [1 ]
Zhang, Yue-Feng [1 ]
Yu, Kai-Huan [1 ]
Wang, Wei-Xing [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary Surg, Wuhan 430060, Hubei, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; CHOLANGIOCARCINOMA; SURVIVAL;
D O I
10.1007/s12672-023-00707-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrahepatic cholangiocarcinoma (ICC) is a fatal disease and the molecular mechanism of its progression remains unknown. Aurora Kinase B (AURKB) is a central regulator of chromosome separation and cytokinesis and is abnormally expressed in a variety of cancer cells. This research aimed to explore the effect of AURKB in occurrence and metastasis of ICC. We found that AURKB showed a progressive up-regulation pattern from normal bile duct tissue to ICC with high invasion. Our data showed that AURKB significantly promoted ICC cell proliferation, induced epithelial-mesenchymal transition (EMT), migration and invasion through gain- and loss- of function experiments. In vivo results consistently showed that AURKB up-regulation not only promoted tumor growth, but also promoted tumor metastasis. Importantly, we discovered that AURKB regulates the expressions of EMT-related genes via PI3K/AKT signaling axis. Herein, our results suggest that AURKB induced EMT through the activation of PI3K/AKT signaling pathway is critical to the progression of ICC, which may be a prospective therapeutic treatment for overcoming ICC metastasis and progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] PI3K signaling in cancer: beyond AKT
    Lien, Evan C.
    Dibble, Christian C.
    Toker, Alex
    CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 62 - 71
  • [42] PI3K/AKT signaling and systemic autoimmunity
    Rahul K. Patel
    Chandra Mohan
    Immunologic Research, 2005, 31 : 47 - 55
  • [43] PI3K/AKT signaling in tumorigenesis and angiogenesis
    Jiang, Bing-Hua
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (07) : 422 - 423
  • [44] Effects of Sorafenib/ZEB1 on the PI3K/AKT Signaling Pathway: Modulation of EMT Progression in Papillary Thyroid Carcinoma
    Li, Xin'na
    Zhang, Xiangzhi
    Zhang, Haiyan
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (11): : 6319 - 6327
  • [45] HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway
    Wang, Shun-chang
    Chai, Da-sen
    Chen, Chuan-bo
    Wang, Zheng-ye
    Wang, Lei
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 75 : 33 - 39
  • [46] circPUM1 Activates the PI3K/AKT Signaling Pathway by Sponging to Promote the Proliferation, Invasion and Glycolysis of Pancreatic Cancer
    Chen, Yang
    Liu, Yuhong
    Tao, Qiang
    Fan, YouWen
    Ma, Chao
    Li, Dong
    Huang, Fei
    Tang, Di
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (11) : 1405 - 1414
  • [47] MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression
    Huang, Longping
    Sun, Jian
    Ma, Yuteng
    Chen, He
    Tian, Chen
    Dong, Ming
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [48] The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma
    Ma, Yang
    Zhang, Yanfang
    Chen, Fangfang
    Liu, Sihua
    Wang, Dongdong
    Lu, Zheng
    Zhang, Dengyong
    Liang, Rui
    HELIYON, 2024, 10 (18)
  • [49] AGEs promote calcification of HASMCs by mediating Pi3k/AKT-GSK3β signaling
    Hou, Qing-Chun
    Wang, Jun-Wei
    Yuan, Gang
    Wang, Yu-Ping
    Xu, Kai-Qiang
    Zhang, Lei
    Xu, Xiong-Fei
    Mao, Wei-Jian
    Liu, Yong
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (06): : 125 - 134
  • [50] Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy
    Yuxuan Zhu
    Jing Yang
    Yongxiang Li
    Jiegou Xu
    Zheng Fang
    Medical Oncology, 40